{"gene":"NYX","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2000,"finding":"NYX encodes nyctalopin, a GPI-anchored small leucine-rich proteoglycan (SLRP) family member; 14 different loss-of-function mutations in NYX cause X-linked complete congenital stationary night blindness (CSNB1), establishing that nyctalopin is required for normal ON-pathway signaling in the retina.","method":"Positional cloning, mutation screening in 22 families, protein domain prediction","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery paper, 14 independent mutations in 22 families, replicated widely across multiple subsequent studies","pmids":["11062471"],"is_preprint":false},{"year":2003,"finding":"Human nyctalopin localizes to the cell surface as a GPI-anchored extracellular protein, with intracellular pools in the ER and Golgi; deletion of the GPI anchor domain causes loss of surface localization and ER/Golgi accumulation; deletion of the ER signal sequence disperses the protein into the cytosol; mouse Nyx similarly localizes to the cell surface despite lacking a predicted GPI anchor. Pathogenic LRR-region mutations do not alter subcellular localization.","method":"Expression of V5-tagged wild-type and mutant NYX constructs in COS-7 and HeLa cells; sequential live-cell surface staining followed by detergent extraction and intracellular staining; deletion mutagenesis","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1–2 — direct cell-surface localization assay with domain deletion mutagenesis, multiple constructs and cell lines, functional consequences of each deletion defined","pmids":["14507859"],"is_preprint":false},{"year":2003,"finding":"Mouse Nyx (orthologue of human NYX) is expressed in cells of the inner nuclear layer and ganglion cell layer of the adult retina and is expressed throughout postnatal retinal development, indicating a role in inner retinal circuitry.","method":"RT-PCR across tissues, RNA in situ hybridization, immunohistochemistry with Nyx-specific antibodies in mouse and rat retinas","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — direct localization by IHC and ISH in two species with developmental time course","pmids":["12714669"],"is_preprint":false},{"year":2004,"finding":"Nyctalopin acts principally or exclusively within the retinal ON-pathway at the level of depolarizing (ON) bipolar cells; pharmacological blockade of ON-pathway depolarizing bipolar cells with APB in non-human primates fully recapitulates the ERG abnormalities of CSNB1-NYX patients, while OFF-pathway blockade does not.","method":"ERG recordings in genotyped CSNB1-NYX human patients and intravitreal APB/PDA injection in anesthetized non-human primates; comparison of photopic sinusoidal and rapid-on/off-ramp flicker ERG responses","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 2 — pharmacological epistasis in primate model replicated phenotype of human NYX mutations, orthogonal stimulation paradigms","pmids":["15331616"],"is_preprint":false},{"year":2001,"finding":"Defective nyctalopin (NYX) prevents detectable signal transmission through ON rod bipolar cells (slow rod ERG pathway absent in CSNB1 patients), but residual transmission through rod-cone gap junctions (fast rod ERG pathway) persists, indicating nyctalopin is specifically required for the rod bipolar–AII amacrine cell pathway.","method":"Scotopic 15-Hz flicker ERG at multiple intensities in 11 CSNB1 patients with NYX mutations vs. 22 controls; separate analysis of slow and fast rod ERG pathways","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — pathway dissection by distinct ERG protocols in genetically confirmed NYX mutation carriers, multiple patients","pmids":["11581222"],"is_preprint":false},{"year":2006,"finding":"The upstream regulatory sequences of the nyx gene drive expression in ON-bipolar cells; nyx::MYFP transgenic zebrafish show that bipolar axonal terminals labeled by nyx regulatory sequences laminate in the inner half of the IPL (consistent with ON-bipolar identity), and live imaging reveals that axonal terminal development proceeds through filopodial exploration followed by establishment of stable boutons.","method":"Transgenic zebrafish expressing MYFP under nyx regulatory sequences; time-lapse confocal and two-photon live imaging of retinal bipolar cell axonal development","journal":"Visual neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vivo imaging in transgenic model, functional context of nyx promoter activity established, but mechanistic detail on nyctalopin protein function itself is indirect","pmids":["17020638"],"is_preprint":false},{"year":2037,"finding":"A noncoding c.-57G>A variant in the 5' UTR/exon 1 of NYX causes abnormal splicing of the NYX transcript confirmed by minigene assay, predicted to reduce nyctalopin production and resulting in a milder cCSNB phenotype without high myopia.","method":"Whole genome sequencing, in silico splice prediction tools, minigene splicing assay","journal":"Acta ophthalmologica","confidence":"Medium","confidence_rationale":"Tier 2 — minigene assay functionally validates splicing impact; single patient, single lab","pmids":["41729106"],"is_preprint":false},{"year":2022,"finding":"In Nyx mutant mice (which lack functional nyctalopin), retinal ganglion cells show oscillatory activity and expanded axonal projections to the dLGN with desegregation of retinal projections; receptive field sizes of green-light preferring RGCs are decreased (not increased) relative to wild-type, while UV-light preferring RGC receptive fields are larger than green-preferring RGCs in both WT and Nyx mice.","method":"Multi-electrode array (MEA) recordings of retinal ganglion cell receptive fields in Nyx mutant vs. wild-type mice","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — direct electrophysiological measurement in genetic mouse model; single study","pmids":["35328623"],"is_preprint":false}],"current_model":"Nyctalopin (NYX) is a GPI-anchored extracellular leucine-rich proteoglycan expressed on the surface of ON-bipolar cells in the retina, where it is required for signal transmission through the ON (depolarizing) bipolar cell pathway — specifically through rod bipolar cells — such that loss-of-function mutations abolish the rod bipolar–AII amacrine cell (slow rod) pathway while sparing residual rod-cone gap junction (fast rod) transmission, collectively causing the ON-pathway deficit characteristic of X-linked complete congenital stationary night blindness (CSNB1)."},"narrative":{"teleology":[{"year":2000,"claim":"Positional cloning identified NYX as the gene mutated in X-linked complete CSNB (CSNB1), establishing that this GPI-anchored leucine-rich proteoglycan is required for normal ON-pathway retinal signaling.","evidence":"Positional cloning and mutation screening across 22 families identifying 14 independent loss-of-function mutations","pmids":["11062471"],"confidence":"High","gaps":["Molecular mechanism by which nyctalopin supports ON-pathway signaling unknown","Cell-type-specific expression within the retina not yet resolved","No direct protein interaction partners identified"]},{"year":2001,"claim":"ERG pathway dissection in CSNB1 patients showed that nyctalopin is specifically required for the rod bipolar–AII amacrine (slow rod) pathway, while the rod-cone gap junction (fast rod) pathway remains functional, localizing the defect to ON bipolar cell signaling rather than photoreceptor function.","evidence":"Scotopic 15 Hz flicker ERG at multiple intensities in 11 genetically confirmed NYX-mutant patients versus 22 controls","pmids":["11581222"],"confidence":"High","gaps":["Whether the defect is in synaptic input, intrinsic bipolar cell physiology, or both is unresolved","Cone ON-bipolar cell involvement not separately tested"]},{"year":2003,"claim":"Subcellular localization studies demonstrated that nyctalopin reaches the plasma membrane via its GPI anchor and signal peptide; pathogenic LRR-region mutations do not alter trafficking, implying these mutations disrupt an extracellular interaction rather than protein localization.","evidence":"V5-tagged wild-type and mutant NYX constructs expressed in COS-7 and HeLa cells with sequential live-cell surface and intracellular staining, plus deletion mutagenesis","pmids":["14507859"],"confidence":"High","gaps":["Identity of the extracellular interaction partner(s) of the LRR domain remains unknown","Surface localization shown in heterologous cells, not retinal neurons"]},{"year":2003,"claim":"In situ hybridization and immunohistochemistry localized Nyx expression to the inner nuclear layer and ganglion cell layer throughout postnatal retinal development, consistent with a role in inner retinal (bipolar/ganglion cell) circuitry.","evidence":"RT-PCR, RNA in situ hybridization, and IHC with Nyx-specific antibodies in mouse and rat retinas across developmental stages","pmids":["12714669"],"confidence":"High","gaps":["Whether expression in ganglion cells is functionally relevant or incidental is unclear","Protein-level localization to specific subcellular compartments within bipolar cells not resolved"]},{"year":2004,"claim":"Pharmacological blockade of ON-bipolar cells with APB in primates fully recapitulated CSNB1 ERG abnormalities, providing epistatic evidence that nyctalopin acts principally or exclusively at the depolarizing (ON) bipolar cell level.","evidence":"Intravitreal APB and PDA injections in anesthetized non-human primates with ERG comparison to genotyped CSNB1-NYX human patients","pmids":["15331616"],"confidence":"High","gaps":["Whether nyctalopin acts upstream (e.g., at the mGluR6 signaling complex) or downstream within the ON-bipolar cell is unresolved","Direct physical or signaling relationship between nyctalopin and the mGluR6/TRPM1 cascade not tested"]},{"year":2006,"claim":"nyx regulatory sequences drive expression specifically in ON-bipolar cells in vivo, and live imaging of nyx-expressing bipolar axon terminals revealed a developmental sequence of filopodial exploration followed by bouton stabilization.","evidence":"Transgenic zebrafish expressing MYFP under nyx regulatory elements; time-lapse confocal and two-photon imaging","pmids":["17020638"],"confidence":"Medium","gaps":["This reports promoter activity, not protein function; nyctalopin's role in axon terminal development is not directly tested","Cross-species relevance to mammalian ON-bipolar cell development not confirmed"]},{"year":2022,"claim":"Nyx-null mice exhibit oscillatory ganglion cell firing and expanded, desegregated retinogeniculate projections, demonstrating that loss of ON-pathway signaling through nyctalopin has circuit-level consequences beyond the bipolar cell.","evidence":"Multi-electrode array recordings of retinal ganglion cell receptive fields in Nyx mutant versus wild-type mice","pmids":["35328623"],"confidence":"Medium","gaps":["Whether the circuit remodeling is a direct consequence of absent ON signaling or involves a separate developmental role of nyctalopin is not distinguished","Single study; independent replication in a second model system not available"]},{"year":null,"claim":"The direct molecular interaction partners of nyctalopin's extracellular LRR domain — and the mechanism by which it enables ON-bipolar cell depolarization (e.g., interaction with TRPM1, GRM6, or another transduction component) — remain unidentified from the discovery timeline.","evidence":"","pmids":[],"confidence":"High","gaps":["No binding partner for the LRR domain identified","Relationship to TRPM1/mGluR6 signaling complex not directly tested","No structural model of nyctalopin available"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,0]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,3,4]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,3,4]}],"complexes":[],"partners":[],"other_free_text":[]},"mechanistic_narrative":"Nyctalopin (NYX) is a GPI-anchored small leucine-rich proteoglycan expressed on the surface of retinal ON-bipolar cells, where it is essential for depolarizing (ON) bipolar cell signal transmission in the rod and cone pathways [PMID:11062471, PMID:15331616]. The protein is targeted to the plasma membrane via an N-terminal signal peptide and a C-terminal GPI anchor; deletion of either domain disrupts surface localization [PMID:14507859]. Loss-of-function mutations in NYX abolish signal transmission through the rod bipolar–AII amacrine cell (slow rod) pathway while sparing residual rod-cone gap junction signaling, and cause X-linked complete congenital stationary night blindness (CSNB1) [PMID:11062471, PMID:11581222]. In Nyx-null mice, the ON-pathway deficit leads to oscillatory retinal ganglion cell activity and desegregated retinogeniculate projections, indicating that nyctalopin-dependent ON signaling shapes downstream visual circuit organization [PMID:35328623]."},"prefetch_data":{"uniprot":{"accession":"Q9GZU5","full_name":"Nyctalopin","aliases":[],"length_aa":476,"mass_kda":51.5,"function":"Required for normal vision. Is a critical factor for light-induced depolarization of retinal ON-bipolar cells, likely acting as a scaffold for TRPM1 and GRM6. Required for TRPM1 trafficking to dendritic tips of ON-bipolar cells","subcellular_location":"Secreted, extracellular space, extracellular matrix; Cell projection, dendrite; Postsynapse","url":"https://www.uniprot.org/uniprotkb/Q9GZU5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NYX","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NYX","total_profiled":1310},"omim":[{"mim_id":"613216","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C","url":"https://www.omim.org/entry/613216"},{"mim_id":"603576","title":"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1","url":"https://www.omim.org/entry/603576"},{"mim_id":"310500","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A","url":"https://www.omim.org/entry/310500"},{"mim_id":"300278","title":"NYCTALOPIN; NYX","url":"https://www.omim.org/entry/300278"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NYX"},"hgnc":{"alias_symbol":["CLRP","CSNB1A"],"prev_symbol":["CSNB1","CSNB4"]},"alphafold":{"accession":"Q9GZU5","domains":[{"cath_id":"3.80.10.10","chopping":"26-161","consensus_level":"medium","plddt":94.5486,"start":26,"end":161},{"cath_id":"3.80.10.10","chopping":"172-337","consensus_level":"medium","plddt":95.1584,"start":172,"end":337},{"cath_id":"-","chopping":"341-390","consensus_level":"medium","plddt":89.3144,"start":341,"end":390}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZU5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZU5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZU5-F1-predicted_aligned_error_v6.png","plddt_mean":81.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NYX","jax_strain_url":"https://www.jax.org/strain/search?query=NYX"},"sequence":{"accession":"Q9GZU5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZU5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZU5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZU5"}},"corpus_meta":[{"pmid":"11062471","id":"PMC_11062471","title":"Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11062471","citation_count":270,"is_preprint":false},{"pmid":"2574143","id":"PMC_2574143","title":"Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3.","date":"1989","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2574143","citation_count":61,"is_preprint":false},{"pmid":"15331616","id":"PMC_15331616","title":"Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness.","date":"2004","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/15331616","citation_count":59,"is_preprint":false},{"pmid":"17020638","id":"PMC_17020638","title":"In vivo development of retinal ON-bipolar cell axonal terminals visualized in nyx::MYFP transgenic zebrafish.","date":"2006","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17020638","citation_count":52,"is_preprint":false},{"pmid":"17392683","id":"PMC_17392683","title":"Mutations in NYX of individuals with high myopia, but without night blindness.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17392683","citation_count":39,"is_preprint":false},{"pmid":"29099938","id":"PMC_29099938","title":"NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.","date":"2018","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29099938","citation_count":34,"is_preprint":false},{"pmid":"15761389","id":"PMC_15761389","title":"Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15761389","citation_count":34,"is_preprint":false},{"pmid":"11581222","id":"PMC_11581222","title":"Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11581222","citation_count":32,"is_preprint":false},{"pmid":"12552565","id":"PMC_12552565","title":"Mutations in the CACNA1F and NYX genes in British CSNBX families.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12552565","citation_count":32,"is_preprint":false},{"pmid":"14507859","id":"PMC_14507859","title":"NYX (nyctalopin on chromosome X), the gene mutated in congenital stationary night blindness, encodes a cell surface protein.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/14507859","citation_count":29,"is_preprint":false},{"pmid":"23406521","id":"PMC_23406521","title":"A novel missense mutation in the NYX gene associated with high myopia.","date":"2013","source":"Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)","url":"https://pubmed.ncbi.nlm.nih.gov/23406521","citation_count":23,"is_preprint":false},{"pmid":"12714669","id":"PMC_12714669","title":"Isolation of the mouse nyctalopin gene nyx and expression studies in mouse and rat retina.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12714669","citation_count":23,"is_preprint":false},{"pmid":"29986951","id":"PMC_29986951","title":"NYX-2925 Is a Novel N-Methyl-d-Aspartate Receptor Modulator that Induces Rapid and Long-Lasting Analgesia in Rat Models of Neuropathic Pain.","date":"2018","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29986951","citation_count":21,"is_preprint":false},{"pmid":"1740347","id":"PMC_1740347","title":"Mapping of locus for X-linked congenital stationary night blindness (CSNB1) proximal to DXS7.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1740347","citation_count":21,"is_preprint":false},{"pmid":"31967361","id":"PMC_31967361","title":"NYX-458 Improves Cognitive Performance in a Primate Parkinson's Disease Model.","date":"2020","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/31967361","citation_count":18,"is_preprint":false},{"pmid":"16670814","id":"PMC_16670814","title":"CSNB1 in Chinese families associated with novel mutations in NYX.","date":"2006","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16670814","citation_count":17,"is_preprint":false},{"pmid":"9418727","id":"PMC_9418727","title":"Localization of CSNBX (CSNB4) between the retinitis pigmentosa loci RP2 and RP3 on proximal Xp.","date":"1997","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/9418727","citation_count":16,"is_preprint":false},{"pmid":"12397430","id":"PMC_12397430","title":"Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene.","date":"2002","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/12397430","citation_count":16,"is_preprint":false},{"pmid":"25802485","id":"PMC_25802485","title":"NYX mutations in four families with high myopia with or without CSNB1.","date":"2015","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/25802485","citation_count":14,"is_preprint":false},{"pmid":"18617546","id":"PMC_18617546","title":"A common NYX mutation in Flemish patients with X linked CSNB.","date":"2008","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/18617546","citation_count":14,"is_preprint":false},{"pmid":"30242962","id":"PMC_30242962","title":"NYX-2925, A Novel N-methyl-D-aspartate Receptor Modulator: A First-in-Human, Randomized, Double-blind Study of Safety and Pharmacokinetics in Adults.","date":"2018","source":"Clinical and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/30242962","citation_count":13,"is_preprint":false},{"pmid":"22735794","id":"PMC_22735794","title":"Mutation screening of TRPM1, GRM6, NYX and CACNA1F genes in patients with congenital stationary night blindness.","date":"2012","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22735794","citation_count":10,"is_preprint":false},{"pmid":"24084093","id":"PMC_24084093","title":"Ultrastructural localization of GPR179 and the impact of mutant forms on retinal function in CSNB1 patients and a mouse model.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24084093","citation_count":10,"is_preprint":false},{"pmid":"21947599","id":"PMC_21947599","title":"An extended 15 Hz ERG protocol (2): data of normal subjects and patients with achromatopsia, CSNB1, and CSNB2.","date":"2011","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21947599","citation_count":8,"is_preprint":false},{"pmid":"16348636","id":"PMC_16348636","title":"Anaerobic Production of Extracellular Polysaccharide by Butyrivibrio fibrisolvens nyx.","date":"1992","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16348636","citation_count":8,"is_preprint":false},{"pmid":"31376158","id":"PMC_31376158","title":"NYX-2925 induces metabotropic N-methyl-d-aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor.","date":"2019","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31376158","citation_count":7,"is_preprint":false},{"pmid":"31826698","id":"PMC_31826698","title":"Novel frameshift mutation in NYX gene in a Russian family with complete congenital stationary night blindness.","date":"2019","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31826698","citation_count":6,"is_preprint":false},{"pmid":"15583843","id":"PMC_15583843","title":"Multifocal oscillatory potentials in CSNB1 and CSNB2 type congenital stationary night blindness.","date":"2005","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15583843","citation_count":6,"is_preprint":false},{"pmid":"23289809","id":"PMC_23289809","title":"Electroretinographic findings in a patient with congenital stationary night blindness due to a novel NYX mutation.","date":"2013","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23289809","citation_count":6,"is_preprint":false},{"pmid":"26234941","id":"PMC_26234941","title":"Two Novel NYX Gene Mutations in the Chinese Families with X-linked Congenital Stationary Night Blindness.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26234941","citation_count":6,"is_preprint":false},{"pmid":"25250444","id":"PMC_25250444","title":"Nyx pholeocola, a new genus and cavernicolous species of tribe Aedini (Diptera: Culicidae) from southern Thailand based on morphological and molecular data.","date":"2013","source":"Zootaxa","url":"https://pubmed.ncbi.nlm.nih.gov/25250444","citation_count":5,"is_preprint":false},{"pmid":"33769208","id":"PMC_33769208","title":"Complete congenital stationary night blindness associated with a novel NYX variant (p.Asn216Lys) in middle-aged and older adult patients.","date":"2021","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33769208","citation_count":5,"is_preprint":false},{"pmid":"12124754","id":"PMC_12124754","title":"Cloning of the cDNA and mRNA expression of CLRP, a complex leucine repeat protein of the Golgi apparatus expressed by specific neurons of the rat brain.","date":"2002","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12124754","citation_count":4,"is_preprint":false},{"pmid":"31909296","id":"PMC_31909296","title":"The NMDAR modulator NYX-2925 alleviates neuropathic pain via a Src-dependent mechanism in the mPFC.","date":"2019","source":"Neurobiology of pain (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/31909296","citation_count":3,"is_preprint":false},{"pmid":"41040268","id":"PMC_41040268","title":"The NMDAR positive allosteric modulator NYX-783 selectively blocks opioid withdrawal conditioned place aversion in mice.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41040268","citation_count":1,"is_preprint":false},{"pmid":"35328623","id":"PMC_35328623","title":"Receptive Field Sizes of Nyx Mouse Retinal Ganglion Cells.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35328623","citation_count":1,"is_preprint":false},{"pmid":"41729106","id":"PMC_41729106","title":"Identification and functional validation of a novel disease-causing variant in the noncoding region of NYX.","date":"2026","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/41729106","citation_count":0,"is_preprint":false},{"pmid":"30980176","id":"PMC_30980176","title":"[Multimodal diagnostic of CSNB1 with NYX gene mutation].","date":"2019","source":"Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/30980176","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.25.666812","title":"Gene augmentation therapy treats mature mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity","date":"2025-07-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.25.666812","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20741,"output_tokens":2024,"usd":0.046291},"stage2":{"model":"claude-opus-4-6","input_tokens":5309,"output_tokens":2028,"usd":0.115867},"total_usd":0.162158,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"NYX encodes nyctalopin, a GPI-anchored small leucine-rich proteoglycan (SLRP) family member; 14 different loss-of-function mutations in NYX cause X-linked complete congenital stationary night blindness (CSNB1), establishing that nyctalopin is required for normal ON-pathway signaling in the retina.\",\n      \"method\": \"Positional cloning, mutation screening in 22 families, protein domain prediction\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery paper, 14 independent mutations in 22 families, replicated widely across multiple subsequent studies\",\n      \"pmids\": [\"11062471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human nyctalopin localizes to the cell surface as a GPI-anchored extracellular protein, with intracellular pools in the ER and Golgi; deletion of the GPI anchor domain causes loss of surface localization and ER/Golgi accumulation; deletion of the ER signal sequence disperses the protein into the cytosol; mouse Nyx similarly localizes to the cell surface despite lacking a predicted GPI anchor. Pathogenic LRR-region mutations do not alter subcellular localization.\",\n      \"method\": \"Expression of V5-tagged wild-type and mutant NYX constructs in COS-7 and HeLa cells; sequential live-cell surface staining followed by detergent extraction and intracellular staining; deletion mutagenesis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct cell-surface localization assay with domain deletion mutagenesis, multiple constructs and cell lines, functional consequences of each deletion defined\",\n      \"pmids\": [\"14507859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mouse Nyx (orthologue of human NYX) is expressed in cells of the inner nuclear layer and ganglion cell layer of the adult retina and is expressed throughout postnatal retinal development, indicating a role in inner retinal circuitry.\",\n      \"method\": \"RT-PCR across tissues, RNA in situ hybridization, immunohistochemistry with Nyx-specific antibodies in mouse and rat retinas\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by IHC and ISH in two species with developmental time course\",\n      \"pmids\": [\"12714669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Nyctalopin acts principally or exclusively within the retinal ON-pathway at the level of depolarizing (ON) bipolar cells; pharmacological blockade of ON-pathway depolarizing bipolar cells with APB in non-human primates fully recapitulates the ERG abnormalities of CSNB1-NYX patients, while OFF-pathway blockade does not.\",\n      \"method\": \"ERG recordings in genotyped CSNB1-NYX human patients and intravitreal APB/PDA injection in anesthetized non-human primates; comparison of photopic sinusoidal and rapid-on/off-ramp flicker ERG responses\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis in primate model replicated phenotype of human NYX mutations, orthogonal stimulation paradigms\",\n      \"pmids\": [\"15331616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Defective nyctalopin (NYX) prevents detectable signal transmission through ON rod bipolar cells (slow rod ERG pathway absent in CSNB1 patients), but residual transmission through rod-cone gap junctions (fast rod ERG pathway) persists, indicating nyctalopin is specifically required for the rod bipolar–AII amacrine cell pathway.\",\n      \"method\": \"Scotopic 15-Hz flicker ERG at multiple intensities in 11 CSNB1 patients with NYX mutations vs. 22 controls; separate analysis of slow and fast rod ERG pathways\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway dissection by distinct ERG protocols in genetically confirmed NYX mutation carriers, multiple patients\",\n      \"pmids\": [\"11581222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The upstream regulatory sequences of the nyx gene drive expression in ON-bipolar cells; nyx::MYFP transgenic zebrafish show that bipolar axonal terminals labeled by nyx regulatory sequences laminate in the inner half of the IPL (consistent with ON-bipolar identity), and live imaging reveals that axonal terminal development proceeds through filopodial exploration followed by establishment of stable boutons.\",\n      \"method\": \"Transgenic zebrafish expressing MYFP under nyx regulatory sequences; time-lapse confocal and two-photon live imaging of retinal bipolar cell axonal development\",\n      \"journal\": \"Visual neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo imaging in transgenic model, functional context of nyx promoter activity established, but mechanistic detail on nyctalopin protein function itself is indirect\",\n      \"pmids\": [\"17020638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2037,\n      \"finding\": \"A noncoding c.-57G>A variant in the 5' UTR/exon 1 of NYX causes abnormal splicing of the NYX transcript confirmed by minigene assay, predicted to reduce nyctalopin production and resulting in a milder cCSNB phenotype without high myopia.\",\n      \"method\": \"Whole genome sequencing, in silico splice prediction tools, minigene splicing assay\",\n      \"journal\": \"Acta ophthalmologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — minigene assay functionally validates splicing impact; single patient, single lab\",\n      \"pmids\": [\"41729106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In Nyx mutant mice (which lack functional nyctalopin), retinal ganglion cells show oscillatory activity and expanded axonal projections to the dLGN with desegregation of retinal projections; receptive field sizes of green-light preferring RGCs are decreased (not increased) relative to wild-type, while UV-light preferring RGC receptive fields are larger than green-preferring RGCs in both WT and Nyx mice.\",\n      \"method\": \"Multi-electrode array (MEA) recordings of retinal ganglion cell receptive fields in Nyx mutant vs. wild-type mice\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiological measurement in genetic mouse model; single study\",\n      \"pmids\": [\"35328623\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Nyctalopin (NYX) is a GPI-anchored extracellular leucine-rich proteoglycan expressed on the surface of ON-bipolar cells in the retina, where it is required for signal transmission through the ON (depolarizing) bipolar cell pathway — specifically through rod bipolar cells — such that loss-of-function mutations abolish the rod bipolar–AII amacrine cell (slow rod) pathway while sparing residual rod-cone gap junction (fast rod) transmission, collectively causing the ON-pathway deficit characteristic of X-linked complete congenital stationary night blindness (CSNB1).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Nyctalopin (NYX) is a GPI-anchored small leucine-rich proteoglycan expressed on the surface of retinal ON-bipolar cells, where it is essential for depolarizing (ON) bipolar cell signal transmission in the rod and cone pathways [PMID:11062471, PMID:15331616]. The protein is targeted to the plasma membrane via an N-terminal signal peptide and a C-terminal GPI anchor; deletion of either domain disrupts surface localization [PMID:14507859]. Loss-of-function mutations in NYX abolish signal transmission through the rod bipolar–AII amacrine cell (slow rod) pathway while sparing residual rod-cone gap junction signaling, and cause X-linked complete congenital stationary night blindness (CSNB1) [PMID:11062471, PMID:11581222]. In Nyx-null mice, the ON-pathway deficit leads to oscillatory retinal ganglion cell activity and desegregated retinogeniculate projections, indicating that nyctalopin-dependent ON signaling shapes downstream visual circuit organization [PMID:35328623].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Positional cloning identified NYX as the gene mutated in X-linked complete CSNB (CSNB1), establishing that this GPI-anchored leucine-rich proteoglycan is required for normal ON-pathway retinal signaling.\",\n      \"evidence\": \"Positional cloning and mutation screening across 22 families identifying 14 independent loss-of-function mutations\",\n      \"pmids\": [\"11062471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism by which nyctalopin supports ON-pathway signaling unknown\",\n        \"Cell-type-specific expression within the retina not yet resolved\",\n        \"No direct protein interaction partners identified\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"ERG pathway dissection in CSNB1 patients showed that nyctalopin is specifically required for the rod bipolar–AII amacrine (slow rod) pathway, while the rod-cone gap junction (fast rod) pathway remains functional, localizing the defect to ON bipolar cell signaling rather than photoreceptor function.\",\n      \"evidence\": \"Scotopic 15 Hz flicker ERG at multiple intensities in 11 genetically confirmed NYX-mutant patients versus 22 controls\",\n      \"pmids\": [\"11581222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the defect is in synaptic input, intrinsic bipolar cell physiology, or both is unresolved\",\n        \"Cone ON-bipolar cell involvement not separately tested\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Subcellular localization studies demonstrated that nyctalopin reaches the plasma membrane via its GPI anchor and signal peptide; pathogenic LRR-region mutations do not alter trafficking, implying these mutations disrupt an extracellular interaction rather than protein localization.\",\n      \"evidence\": \"V5-tagged wild-type and mutant NYX constructs expressed in COS-7 and HeLa cells with sequential live-cell surface and intracellular staining, plus deletion mutagenesis\",\n      \"pmids\": [\"14507859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the extracellular interaction partner(s) of the LRR domain remains unknown\",\n        \"Surface localization shown in heterologous cells, not retinal neurons\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"In situ hybridization and immunohistochemistry localized Nyx expression to the inner nuclear layer and ganglion cell layer throughout postnatal retinal development, consistent with a role in inner retinal (bipolar/ganglion cell) circuitry.\",\n      \"evidence\": \"RT-PCR, RNA in situ hybridization, and IHC with Nyx-specific antibodies in mouse and rat retinas across developmental stages\",\n      \"pmids\": [\"12714669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether expression in ganglion cells is functionally relevant or incidental is unclear\",\n        \"Protein-level localization to specific subcellular compartments within bipolar cells not resolved\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Pharmacological blockade of ON-bipolar cells with APB in primates fully recapitulated CSNB1 ERG abnormalities, providing epistatic evidence that nyctalopin acts principally or exclusively at the depolarizing (ON) bipolar cell level.\",\n      \"evidence\": \"Intravitreal APB and PDA injections in anesthetized non-human primates with ERG comparison to genotyped CSNB1-NYX human patients\",\n      \"pmids\": [\"15331616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether nyctalopin acts upstream (e.g., at the mGluR6 signaling complex) or downstream within the ON-bipolar cell is unresolved\",\n        \"Direct physical or signaling relationship between nyctalopin and the mGluR6/TRPM1 cascade not tested\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"nyx regulatory sequences drive expression specifically in ON-bipolar cells in vivo, and live imaging of nyx-expressing bipolar axon terminals revealed a developmental sequence of filopodial exploration followed by bouton stabilization.\",\n      \"evidence\": \"Transgenic zebrafish expressing MYFP under nyx regulatory elements; time-lapse confocal and two-photon imaging\",\n      \"pmids\": [\"17020638\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"This reports promoter activity, not protein function; nyctalopin's role in axon terminal development is not directly tested\",\n        \"Cross-species relevance to mammalian ON-bipolar cell development not confirmed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Nyx-null mice exhibit oscillatory ganglion cell firing and expanded, desegregated retinogeniculate projections, demonstrating that loss of ON-pathway signaling through nyctalopin has circuit-level consequences beyond the bipolar cell.\",\n      \"evidence\": \"Multi-electrode array recordings of retinal ganglion cell receptive fields in Nyx mutant versus wild-type mice\",\n      \"pmids\": [\"35328623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the circuit remodeling is a direct consequence of absent ON signaling or involves a separate developmental role of nyctalopin is not distinguished\",\n        \"Single study; independent replication in a second model system not available\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct molecular interaction partners of nyctalopin's extracellular LRR domain — and the mechanism by which it enables ON-bipolar cell depolarization (e.g., interaction with TRPM1, GRM6, or another transduction component) — remain unidentified from the discovery timeline.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No binding partner for the LRR domain identified\",\n        \"Relationship to TRPM1/mGluR6 signaling complex not directly tested\",\n        \"No structural model of nyctalopin available\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```"}